December 3, 2024 - 22:10

In a recent analysis, chart analyst and investor Todd Gordon provided insights into the stock performance of Hims & Hers Health, suggesting that it could potentially double in value. Gordon's examination of the stock charts indicates a bullish trend, highlighting key patterns that may signal future growth for the health-care company.
Hims & Hers Health, known for its telehealth services and wellness products, has been gaining traction in the market. Gordon pointed out several technical indicators that support the notion of upward momentum. He emphasized the importance of monitoring specific price levels and volume trends, which could serve as crucial benchmarks for investors looking to capitalize on potential gains.
As the health-care sector continues to evolve, companies like Hims & Hers are at the forefront of innovative solutions. Investors are keenly watching market dynamics, and Gordon's analysis adds a layer of optimism for those considering positions in this promising stock.
December 2, 2025 - 00:18
New Certificate Program Launched to Tackle Children's Mental Health ChallengesThe School of Social Work has introduced a new certificate program designed to equip future social workers with the skills necessary to address the growing mental health crisis among children and...
December 1, 2025 - 04:30
Health Updates: Louisiana Institutions Awarded Grants and Notable RecognitionsHealth Notes is an occasional listing of health happenings around Louisiana. Recently, several institutions across the state received significant financial support through grants aimed at enhancing...
November 30, 2025 - 14:05
Innovative Strategies by South African Youth Workers to Promote Health on Social MediaSouth African youth workers, despite facing challenges such as limited resources, are leveraging digital tools to effectively disseminate health messages among young people. Recognizing the power...
November 29, 2025 - 23:29
FDA Official Signals Potential Action on Vaccine Approvals Following Internal ReviewAn internal memo from a senior FDA official has raised concerns about the agency`s vaccine approval process. This communication follows a comprehensive internal review that has reportedly connected...